|
NRIX Nurix Therapeutics Inc 1549595 |
| Balance Sheet |
|
Current Assets
|
$456,481,000.00 |
|
Assets
|
$535,540,000.00 |
|
Current Liabilities
|
$72,020,000.00 |
|
Liabilities
|
$132,913,000.00 |
|
Equity
|
$402,627,000.00 |
|
Shares Out
|
103701511.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-168,487,000.00 |
|
Investing Cash Flow
|
$-30,829,000.00 |
| Market Analysis |
Market Cap
|
$2,805,125,872.55 |
|
Price
|
$27.05 |
|
BVPS
|
3.88 |
|
PB
|
6.97 |
|
EPS
|
-0.81 |
|
PS
|
77.55 |
|
FCF
|
$-171,468,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:31 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:21 |
|
| Jan |
Feb |
Mar |
|
|
2026-01-28 |
-0.82 |
|
|
|
| Apr |
May |
Jun |
|
|
2026-04-08 |
-0.79 |
|
|
|
| Jul |
Aug |
Sep |
|
|
2025-07-09 |
-0.52 |
|
|
|
| Oct |
Nov |
Dec |
|
|
2025-10-09 |
-1.03 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NRIX documents filed with the SEC.
NRIX Filings
Clear
